Anemia Research Today is a free monthly online journal that collates and summarizes the latest research about Anemia, including details on symptoms, diagnosis, diet, treatment, causes.

Volume 4 (2007), Issue 4 (April)

1. Presence of the sickle cell trait and preterm delivery in African-American women.
   Obstet Gynecol, 109(4): 870-4. [Abstract] [Full-text]
2. A randomized, parallel-group, open-label trial of recombinant human erythropoietin vs preoperative autologous donation in primary total joint arthroplasty: effect on postoperative vigor and handgrip strength.
   J Arthroplasty, 22(3): 325-33. [Abstract] [Full-text]
3. Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines.
   Transfus Med Rev, 21(2): 118-33. [Abstract] [Full-text]
4. Strategies for managing anemia in hepatitis C patients undergoing antiviral therapy.
   Am J Gastroenterol, 102(4): 880-9. [Abstract] [Full-text]
5. Immune-mediated hemolytic anemia in an eclectus parrot.
   J Am Vet Med Assoc, 230(7): 1028-31. [Abstract] [Full-text]
6. Immune-mediated erythroid and megakaryocytic aplasia in a cat.
   J Am Vet Med Assoc, 230(7): 1024-7. [Abstract] [Full-text]
7. Myocardial and liver iron status using a fast T*2 quantitative MRI (T*2qMRI) technique.
   Magn Reson Med, 57(4): 742-53. [Abstract] [Full-text]
8. Physician-diagnosed asthma and acute chest syndrome: associations with NOS polymorphisms.
   Pediatr Pulmonol, 42(4): 332-8. [Abstract] [Full-text]
9. Iron absorption from wheat flour: effects of lemonade and chamomile infusion.
   Nutrition, 23(4): 296-300. [Abstract] [Full-text]
10. A comprehensive strategy for the subtyping of patients with Fanconi anaemia: conclusions from the Spanish Fanconi Anemia Research Network.
    J Med Genet, 44(4): 241-9. [Abstract] [Full-text]
11. Sickle cell disease: old discoveries, new concepts, and future promise.
    J Clin Invest, 117(4): 850-8. [Abstract] [Full-text]
12. Total iron binding capacity or transferrin concentration alone outperforms iron and saturation indices in predicting iron deficiency.
    Clin Chim Acta, 380(1): 203-7. [Abstract] [Full-text]
13. The impact of anemia on quality of life and healthcare resource utilization in patients with HIV/AIDS receiving antiretroviral therapy.
    Curr Med Res Opin, 23(4): 803-10. [Abstract] [Full-text]
14. Naloxone acts as a potent analgesic in transgenic mouse models of sickle cell anemia.
    Proc Natl Acad Sci U S A, 104(14): 6061-5. [Abstract] [Full-text]
15. A mathematical model of twin-twin transfusion syndrome with pulsatile arterial circulations.
    Am J Physiol Regul Integr Comp Physiol, 292(4): R1519-31. [Abstract] [Full-text]
16. Genetic polymorphisms associated with priapism in sickle cell disease.
    Br J Haematol, 137(3): 262-7. [Abstract] [Full-text]
17. Anaemia characterises patients with myelofibrosis harbouring Mpl mutation.
    Br J Haematol, 137(3): 244-7. [Abstract] [Full-text]
18. Recent developments in the understanding and management of paroxysmal nocturnal haemoglobinuria.
    Br J Haematol, 137(3): 181-92. [Abstract] [Full-text]
19. Abcb7, the gene responsible for X-linked sideroblastic anemia with ataxia, is essential for hematopoiesis.
    Blood, 109(8): 3567-9. [Abstract] [Full-text]
20. Pathogenic proline mutation in the linker between spectrin repeats: disease caused by spectrin unfolding.
    Blood, 109(8): 3538-43. [Abstract] [Full-text]
21. RNA silencing of the mitochondrial ABCB7 transporter in HeLa cells causes an iron-deficient phenotype with mitochondrial iron overload.
    Blood, 109(8): 3552-9. [Abstract] [Full-text]
22. Molecular basis of glutathione reductase deficiency in human blood cells.
    Blood, 109(8): 3560-6. [Abstract] [Full-text]
23. Validity assessment of nine discriminant functions used for the differentiation between iron deficiency anemia and thalassemia minor.
    J Trop Pediatr, 53(2): 93-7. [Abstract] [Full-text]
24. Diamond-Blackfan anemia: erythropoiesis lost in translation.
    Blood, 109(8): 3152-4. [Abstract] [Full-text]
25. Endothelial Lu/BCAM glycoproteins are novel ligands for red blood cell alpha4beta1 integrin: role in adhesion of sickle red blood cells to endothelial cells.
    Blood, 109(8): 3544-51. [Abstract] [Full-text]
26. Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia.
    Blood, 109(8): 3219-24. [Abstract] [Full-text]
27. Thalassemia in Iran: epidemiology, prevention, and management.
    J Pediatr Hematol Oncol, 29(4): 233-8. [Abstract] [Full-text]
28. Iron requirements, absorption and metabolism in infancy and childhood.
    Curr Opin Clin Nutr Metab Care, 10(3): 329-35. [Abstract] [Full-text]
29. The pathophysiology, prevention, and treatment of stroke in sickle cell disease.
    Curr Opin Hematol, 14(3): 191-7. [Abstract] [Full-text]
30. Congestive heart failure-related anemia and a role for erythropoietin.
    Int J Cardiol, 117(3): 296-305. [Abstract] [Full-text]
31. Physiologically important secondary modifications of red cell membrane in hereditary spherocytosis-evidence for in vivo oxidation and lipid rafts protein variations.
    Blood Cells Mol Dis, 38(3): 210-20. [Abstract] [Full-text]
32. The treatment of anemia in chronic kidney disease: understandings in 2006.
    Curr Opin Nephrol Hypertens, 16(3): 267-71. [Abstract] [Full-text]
33. Albuminuria and renal function in homozygous sickle cell disease: observations from a cohort study.
    Arch Intern Med, 167(7): 701-8. [Abstract] [Full-text]
34. Extramedullary haematopoiesis in thalassaemia major causing spinal cord compression.
    Australas Radiol, 51(2): 168-71. [Abstract] [Full-text]
35. A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance.
    Circulation, 115(14): 1876-84. [Abstract] [Full-text]
36. Factors and markers of growth hormone secretion and gonadal function in Fanconi anemia.
    Growth Horm IGF Res, 17(2): 122-9. [Abstract] [Full-text]
37. The study of sequence configuration and functional impact of the (AC)n(AT)xTy motif in human beta-globin gene promoter.
    Am J Hematol, 82(5): 342-8. [Abstract] [Full-text]
38. Coexistence of Southeast Asian ovalocytosis and beta-thalassemia: a molecular and hematological analysis.
    Am J Hematol, 82(5): 381-5. [Abstract] [Full-text]
39. Interleukin-1beta inhibits the hypoxic inducibility of the erythropoietin enhancer by suppressing hepatocyte nuclear factor-4alpha.
    Cell Mol Life Sci, 64(7): 989-98. [Abstract] [Full-text]
40. Transfusion of red blood cells: no impact on length of hospital stay in moderately anaemic parturients.
    Acta Anaesthesiol Scand, 51(5): 565-9. [Abstract] [Full-text]
41. Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype.
    Am J Hum Genet, 80(5): 895-910. [Abstract] [Full-text]
42. The prognostic value of anaemia at different treatment times in patients with locally advanced head and neck cancer treated with surgery and postoperative radiotherapy.
    Clin Oncol (R Coll Radiol), 19(4): 228-33. [Abstract] [Full-text]
43. Three-year single institution audit on transfusion requirements in oncology patients.
    Clin Oncol (R Coll Radiol), 19(4): 223-7. [Abstract] [Full-text]
44. Liver transplantation in children with sickle-cell disease.
    Liver Transpl, 13(4): 505-8. [Abstract] [Full-text]
45. Diagnosing PNH with FLAER and multiparameter flow cytometry.
    Cytometry B Clin Cytom, 72(3): 167-77. [Abstract] [Full-text]
46. Candidate gene mutation analysis in idiopathic acquired sideroblastic anemia (refractory anemia with ringed sideroblasts).
    Leuk Res, 31(5): 623-8. [Abstract] [Full-text]
47. Anemia as a risk factor for kidney function decline in individuals with heart failure.
    Am J Cardiol, 99(8): 1137-42. [Abstract] [Full-text]
48. Impact of blood transfusions in patients presenting with anemia and suspected acute coronary syndrome.
    Am J Cardiol, 99(8): 1119-21. [Abstract] [Full-text]
49. The influence of anaemia on stroke prognosis and its relation to N-terminal pro-brain natriuretic peptide.
    Eur J Neurol, 14(5): 477-82. [Abstract] [Full-text]
50. Capsule endoscopy changes patient management in routine clinical practice.
    Dig Dis Sci, 52(5): 1382-6. [Abstract] [Full-text]
51. Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patients.
    Bone Marrow Transplant, 39(9): 555-61. [Abstract] [Full-text]
52. Complete factor H deficiency-associated atypical hemolytic uremic syndrome in a neonate.
    Pediatr Nephrol, 22(6): 874-80. [Abstract] [Full-text]
53. Transfusion strategies for patients in pediatric intensive care units.
    N Engl J Med, 356(16): 1609-19. [Abstract] [Full-text]
54. Steroid hormones for contraception in women with sickle cell disease.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
55. Piracetam for reducing the incidence of painful sickle cell disease crises.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
56. Antibiotics for treating acute chest syndrome in people with sickle cell disease.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
57. Fluid replacement therapy for acute episodes of pain in people with sickle cell disease.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
58. Treatments for iron-deficiency anaemia in pregnancy.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
59. Gamma interferon suppresses erythropoiesis via interleukin-15.
    Infect Immun, 75(5): 2630-3. [Abstract] [Full-text]
60. Blastocyst biopsy versus cleavage stage biopsy and blastocyst transfer for preimplantation genetic diagnosis of beta-thalassaemia: a pilot study.
    Hum Reprod, 22(5): 1443-9. [Abstract] [Full-text]
61. Delayed cord clamping and haemoglobin levels in infancy: a randomised controlled trial in term babies.
    Trop Med Int Health, 12(5): 603-16. [Abstract] [Full-text]
62. Prognosis and pathological characteristics of five children with non-Shiga toxin-mediated hemolytic uremic syndrome.
    Pediatr Int, 49(2): 196-201. [Abstract] [Full-text]
63. The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulation.
    Mol Immunol, 44(12): 3162-7. [Abstract] [Full-text]
64. EPO in cancer anemia: benefits and potential risks.
    Crit Rev Oncol Hematol, 62(2): 119-25. [Abstract] [Full-text]
65. Allogeneic stem cell transplantation for aplastic anemia.
    Biol Blood Marrow Transplant, 13(5): 505-16. [Abstract] [Full-text]
66. Fanconi's anemia: clinical and radiographic oral manifestations.
    Oral Dis, 13(3): 291-5. [Abstract] [Full-text]
67. Passive smoking as a risk factor of anemia in young children aged 0-35 months in Jordan.
    BMC Pediatr, 7: 16. [Abstract] [Full-text]
68. Anemia correction in malignancy management: threat or opportunity?
    Gynecol Oncol, 105(2): 517-29. [Abstract] [Full-text]
69. Incidence of symptomatic deep venous thrombosis with epoetin alfa or darbepoetin alfa treatment of anemia in patients with ovarian or primary peritoneal cancer.
    Gynecol Oncol, 105(2): 414-7. [Abstract] [Full-text]
70. Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation.
    Blood, 109(9): 4038-44. [Abstract] [Full-text]
71. Iron chelation regulates cyclin D1 expression via the proteasome: a link to iron deficiency-mediated growth suppression.
    Blood, 109(9): 4045-54. [Abstract] [Full-text]
72. Liver involvement in acute vaso-occlusive crisis of sickle cell disease: prevalence and predisposing factors.
    Scand J Gastroenterol, 42(4): 499-507. [Abstract] [Full-text]
73. Skull bone infarctive crisis and deep vein thrombosis in homozygous sickle cell disease- case report and review of the literature.
    Hematology, 12(2): 169-74. [Abstract] [Full-text]
74. Mixed-type autoimmune haemolytic anaemia: unusual cases and a case associated with splenic T-cell angioimmunoblastic non-Hodgkin's lymphoma.
    Hematology, 12(2): 159-62. [Abstract] [Full-text]
75. Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
    Hematology, 12(2): 117-21. [Abstract] [Full-text]
76. Low oxygen tension alleviates oxidative damage and delays cellular senescence in G6PD-deficient cells.
    Free Radic Res, 41(5): 571-9. [Abstract] [Full-text]
77. Nononcologic use of human recombinant erythropoietin therapy in hospitalized patients.
    Arch Intern Med, 167(8): 840-6. [Abstract] [Full-text]
78. Case control study of psychosocial morbidity in beta thalassemia major.
    J Pediatr, 150(5): 516-20. [Abstract] [Full-text]
79. Binasal visual field defects from simultaneous bilateral retinal infarctions in sickle cell disease.
    Am J Ophthalmol, 143(5): 893-6. [Abstract] [Full-text]
80. Pathogenic mitochondrial DNA-induced respiration defects in hematopoietic cells result in anemia by suppressing erythroid differentiation.
    FEBS Lett, 581(9): 1910-6. [Abstract] [Full-text]
81. Emergency department management of acute pain episodes in sickle cell disease.
    Acad Emerg Med, 14(5): 419-25. [Abstract] [Full-text]
82. Effect of carnitine supplementation on lipid profile and anemia in children on chronic dialysis.
    Pediatr Nephrol, 22(5): 727-33. [Abstract] [Full-text]
83. Darbepoetin, effective treatment of anaemia in paediatric patients with chronic renal failure.
    Pediatr Nephrol, 22(5): 708-14. [Abstract] [Full-text]
84. How to define anemia in children with chronic kidney disease?
    Pediatr Nephrol, 22(5): 702-7. [Abstract] [Full-text]
85. Reengineering clinical operations in a medical practice to optimize the management of anemia of chronic kidney disease.
    Pharmacotherapy, 27(5): 734-44. [Abstract] [Full-text]
86. Prevalence of anemia in clinic patients with heart failure and cost analysis of epoetin treatment.
    Pharmacotherapy, 27(5): 707-14. [Abstract] [Full-text]
87. Twin-twin transfusion syndrome modeling.
    Ann N Y Acad Sci, 1101: 215-34. [Abstract] [Full-text]
88. Children with sickle cell disease and human immunodeficiency virus-1 infection: use of inpatient care services in the United States.
    Pediatr Infect Dis J, 26(5): 406-10. [Abstract] [Full-text]
89. The radiological manifestations of sickle cell disease.
    Clin Radiol, 62(6): 528-38. [Abstract] [Full-text]
90. Adequacy of dietary intake declines with age in children with sickle cell disease.
    J Am Diet Assoc, 107(5): 843-8. [Abstract] [Full-text]
91. Efficacy of radiofrequency ablation for twin-reversed arterial perfusion sequence.
    Am J Obstet Gynecol, 196(5): 459.e1-4. [Abstract] [Full-text]
92. Neonatal outcome in preterm monochorionic twins with twin-to-twin transfusion syndrome after intrauterine treatment with amnioreduction or fetoscopic laser surgery: comparison with dichorionic twins.
    Am J Obstet Gynecol, 196(5): 450.e1-7. [Abstract] [Full-text]

© 2004-2008 Anemia Research Today. All Rights Reserved.